Publication Name	World Journal of Clinical Infectious Diseases
Manuscript ID	21426
Country	Italy

Received	2015-07-11 09:16
Peer-Review Started	2015-07-15 09:22
First Decision by Editorial Office Director
Return for Revision	2015-08-25 18:51
Revised	2015-08-28 18:57
Publication Fee Transferred
Second Decision by Editor	2015-10-08 12:26
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2015-10-19 15:37
Articles in Press	2015-10-19 15:38
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-11-19 10:12
Publish the Manuscript Online	2015-11-27 16:31

ISSN	2220-3176 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	New biomarkers for clinical management of hepatitis C virus infected patients
Manuscript Source	Invited Manuscript
All Author List	Alessandra Biasiolo, Andrea Martini and Patrizia Pontisso
Funding Agency and Grant Number
Corresponding Author	Patrizia Pontisso, Professor, Department of Medicine, University of Padua, Via Giustiniani, 2, 35128 Padua, Italy. patrizia@unipd.it
Key Words	Hepatitis C virus infection; Biomarkers; Liver disease progression; Hepatocellular carcinoma
Core Tip	Hepatitis C virus (HCV) infection is a major cause of cirrhosis and hepatocellular carcinoma (HCC), leading to liver failure and/or liver transplantation. The current knowledge on the new promising biomarkers, able to predict the progression of HCV-related liver disease and HCC, has been the focus of this editorial.
Publish Date	2015-11-27 16:31
Citation	Biasiolo A, Martini A, Pontisso P. New biomarkers for clinical management of hepatitis C virus infected patients. World J Clin Infect Dis 2015; 5(4): 59-66
URL	http://www.wjgnet.com/2220-3176/full/v5/i4/59.htm
DOI	http://dx.doi.org/10.5495/wjcid.v5.i4.59

Full Article (PDF)	WJCID-5-59.pdf
Full Article (Word)	WJCID-5-59.doc
Manuscript File	21426-Review.doc
Answering Reviewers	21426-Answering reviewers.pdf
Audio Core Tip	21426-Audio core tip.wma
Conflict-of-Interest Disclosure Form	21426-Conflict-of-interest statement.pdf
Copyright License Agreement	21426-Copyright assignment.pdf
Peer-review Report	21426-Peer-review(s).pdf
Scientific Misconduct Check	21426-Scientific misconduct check.pdf
Scientific Editor Work List	21426-Scientific editor work list.pdf